Crystal form of lornoxicam and preparation method thereof

A technology of lornoxicam and crystal form, applied in organic chemistry methods, organic chemistry and other directions, can solve problems such as poor stability of lornoxicam crystal form

Pending Publication Date: 2022-03-22
BEIJING JINCHENG TAIER PHARMA CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The existing lornoxicam crystal form I is a triclinic crystal system, most of which are rectangular parallelepiped and the lornoxicam crystal form II orthorhombic crystal system is mostly an ellipsoid, but the existing lornoxicam crystal form has poor stability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystal form of lornoxicam and preparation method thereof
  • Crystal form of lornoxicam and preparation method thereof
  • Crystal form of lornoxicam and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Add 4.00g of lornoxicam solid and 63.16g of acetone into the four-necked reaction flask, start stirring, start heating after stirring and mixing, and add 5wt.% potassium hydroxide aqueous solution and 5wt.% triethylamine aqueous solution under the temperature control at 20°C The pH value was adjusted to 8, the reaction system was dissolved, and stirring was continued at 30° C. for 30 minutes after dissolution. Slowly add 10wt.% acetic acid aqueous solution to the clarified solution to adjust the pH figure 2 The crystal morphology under the electron microscope is shown in Figure 5 shown. Table 1 shows the typical characteristic absorption peaks at the diffraction angle 2θ of the X-ray powder diffraction pattern of this crystal form. The TGA diagram of the crystal form is shown in Figure 7 As shown, the DSC diagram is shown in Figure 9 shown. The upper curve in the TGA diagram is based on the right ordinate, and the lower curve is based on the left ordinate.

[00...

Embodiment 2

[0042] Add 4.00 g of lornoxicam solids and 60 g of acetone into a four-necked reaction flask, start stirring, start heating after stirring and mixing, and control the temperature at 15° C. Add 5 wt.% triethylamine aqueous solution to adjust the pH value to 9, and the reaction system dissolves After clearing, continue stirring at 35°C for 30 minutes. Slowly add 10wt.% acetic acid aqueous solution to the clarified solution to adjust the PH<5 of the solution, and yellow crystals are precipitated, kept stirring at 35°C for 30 minutes; the solid filter cake is collected by suction filtration under reduced pressure, and the solid filter cake is placed in vacuum drying In the box, turn on the vacuum pump to evacuate (-0.07MPa~-0.1MPa), vacuum dry at 100°C for 7 hours, then cool down to 35°C, vent the nitrogen, collect the solid to obtain the solid powder of lornoxicam crystal form, Yield 98.7%, purity 99.8%.

Embodiment 3

[0044]Add 4.00g of lornoxicam solids and 64g of acetone into a four-necked reaction flask, start stirring, start heating after stirring and mixing, and add 5wt.% potassium hydroxide aqueous solution and 5wt.% N,N-di The pH value of the aqueous solution of isopropylethylamine was adjusted to 8, the reaction system was dissolved, and stirring was continued at 25° C. for 35 minutes after dissolution. Slowly add 10wt.% acetic acid aqueous solution to the clarified solution to adjust the pH<5 of the solution, and yellow crystals are precipitated, kept stirring at 25°C for 35 minutes; the solid filter cake is collected by vacuum filtration, and the solid filter cake is vacuum-dried In the box, turn on the vacuum pump to evacuate (-0.07MPa~-0.1MPa), vacuum dry at 90°C for 8 hours, then cool down to 25°C, vent the nitrogen, and collect the solid to obtain the solid powder of lornoxicam crystal form. Yield 98.5%, purity 99.7%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a lornoxicam crystal form and a preparation method thereof. The 2 theta diffraction of an X-ray powder diffraction pattern of the lornoxicam crystal form has characteristic diffraction peaks at the positions of 11.930 DEG C, 14.150 DEG C, 14.970 DEG C, 16.400 DEG C, 19.180 DEG C, 20.320 DEG C, 21.430 DEG C, 25.830 DEG C, 27.340 DEG C and 30.390 DEG C. The invention further discloses a preparation method of the lornoxicam crystal form. The organic solvent acetone is selected, so that the risk of methanol solvent residue is reduced, and the crystal form quality is more reliable; and the crystallization temperature condition does not need high-temperature heating, and the crystallization temperature can be completed at room temperature. The crystal form prepared by the invention has good thermal stability, and the TGA thermal weight loss temperature and DSC differential scanning calorimetry data are higher than those of the currently reported crystal form.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a crystal form of lornoxicam and a preparation method thereof. Background technique [0002] Lornoxicam developed by Norway Nycomed Company was first listed in Denmark in October 1997. Its action sites are mainly in the central nervous system and peripheral pain areas, and it has analgesic, anti-inflammatory and antipyretic effects. It is widely used in the treatment of rheumatoid arthritis, rheumatoid arthritis and other diseases clinically. Inflammatory drugs occupy an important position and have good market development prospects. There are not only tablets but also intravenous injections and intramuscular injections. [0003] Chinese patent CN 111004256A discloses a co-crystal of lornoxicam puerarin and its preparation method. The co-crystal has a powder X-ray diffraction pattern represented by the 2θ angle value, and the powder X-ray diffraction is respectively ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D513/04
CPCC07D513/04C07B2200/13
Inventor李洁邢冬野孟庆博贾云芳高银辉刘洪亮赵庆勇
OwnerBEIJING JINCHENG TAIER PHARMA CO LTD